Koga, S., Sekiya, H., Kondru, N., Ross, O. A. & Dickson, D. W. Neuropathology and molecular diagnosis of synucleinopathies. Mol. Neurodegener. 16, 83 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Braak, H. et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 24, 197–211 (2003).

Article  PubMed  Google Scholar 

Ayers, J. I., Paras, N. A. & Prusiner, S. B. Expanding spectrum of prion diseases. Emerg. Top Life Sci. 4, 155–167 (2020).

Article  CAS  PubMed  Google Scholar 

Arotcarena, M.-L. et al. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates. Brain 143, 1462–1475 (2020).

Article  PubMed  Google Scholar 

Sharabi, Y., Vatine, G. D. & Ashkenazi, A. Parkinson’s disease outside the brain: targeting the autonomic nervous system. Lancet Neurol. 20, 868–876 (2021).

Article  CAS  PubMed  Google Scholar 

Wakabayashi, K., Mori, F., Tanji, K., Orimo, S. & Takahashi, H. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol. 120, 1–12 (2010).

Article  PubMed  Google Scholar 

Kim, S. et al. Transneuronal propagation of pathologic α-synuclein from the gut to the brain models Parkinson’s disease. Neuron 103, 627–641 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahn, E. H. et al. Initiation of Parkinson’s disease from gut to brain by δ-secretase. Cell Res. 30, 70–87 (2020).

Article  PubMed  Google Scholar 

Challis, C. et al. Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat. Neurosci. 23, 327–336 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holmqvist, S. et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 128, 805–820 (2014).

Article  PubMed  Google Scholar 

Killinger, B. A. et al. The vermiform appendix impacts the risk of developing Parkinson’s disease. Sci. Transl. Med. 10, eaar5280 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Barbour, R. et al. Red blood cells are the major source of α-synuclein in blood. Neurodegener. Dis. 5, 55–59 (2008).

Article  CAS  PubMed  Google Scholar 

Tian, C. et al. Erythrocytic α-synuclein as a potential biomarker for Parkinson’s disease. Transl. Neurodegener. 8, 15 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gwoździński, K., Janicka, M., Brzeszczyńska, J. & Luciak, M. Changes in red blood cell membrane structure in patients with chronic renal failure. Acta Biochim. Pol. 44, 99–107 (1997).

Article  PubMed  Google Scholar 

Schramm, L. P., Strack, A. M., Platt, K. B. & Loewy, A. D. Peripheral and central pathways regulating the kidney: a study using pseudorabies virus. Brain Res. 616, 251–262 (1993).

Article  CAS  PubMed  Google Scholar 

Baek, S. H. et al. Incident Parkinson’s disease in kidney transplantation recipients: a nationwide population-based cohort study in Korea. Sci Rep. 11, 10541 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, I.-K. et al. Increased risk of Parkinson’s disease in patients with end-stage renal disease: a retrospective cohort study. Neuroepidemiology 42, 204–210 (2014).

Article  PubMed  Google Scholar 

Nam, G. E. et al. Chronic renal dysfunction, proteinuria, and risk of Parkinson’s disease in the elderly. Mov. Disord. 34, 1184–1191 (2019).

Article  PubMed  Google Scholar 

McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863–1872 (2005).

Article  CAS  PubMed  Google Scholar 

Peelaerts, W. et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340–344 (2015).

Article  CAS  PubMed  Google Scholar 

Lin, S.-Y. et al. Association between acute kidney injury and risk of Parkinson disease. Eur. J. Intern. Med. 36, 81–86 (2016).

Article  PubMed  Google Scholar 

Sacino, A. N. et al. Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc. Natl Acad. Sci. USA 111, 10732–10737 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Atik, A., Stewart, T. & Zhang, J. α-Synuclein as a biomarker for Parkinson’s disease. Brain Pathol. 26, 410–418 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barajas, L. & Müller, J. The innervation of the juxtaglomerular apparatus and surrounding tubules: a quantitative analysis by serial section electron microscopy. J. Ultrastruct. Res. 43, 107–132 (1973).

Article  CAS  PubMed  Google Scholar 

Müller, J. & Barajas, L. Electron microscopic and histochemical evidence for a tubular innervation in the renal cortex of the monkey. J. Ultrastruct. Res. 41, 533–549 (1972).

Article  PubMed  Google Scholar 

Calaresu, F. R. & Ciriello, J. Renal afferent nerves affect discharge rate of medullary and hypothalamic single units in the cat. J. Auton. Nerv. Syst. 3, 311–320 (1981).

Article  CAS  PubMed  Google Scholar 

Julian, B. A. et al. Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease. Proteomics Clin. Appl. 3, 1029–1043 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian, D.-Y. et al. Physiological clearance of amyloid-β by the kidney and its therapeutic potential for Alzheimer’s disease. Mol. Psychiatry 26, 6074–6082 (2021).

Article  CAS  PubMed  Google Scholar 

Viggiano, D. et al. Mechanisms of cognitive dysfunction in CKD. Nat. Rev. Nephrol. 16, 452–469 (2020).

Article  PubMed  Google Scholar 

Rosner, M. H., Husain-Syed, F., Reis, T., Ronco, C. & Vanholder, R. Uremic encephalopathy. Kidney Int. 101, 227–241 (2022).

Article  CAS  PubMed  Google Scholar 

Li, X.-Y. et al. Alterations of erythrocytic phosphorylated α-synuclein in different subtypes and stages of Parkinson’s disease. Front. Aging Neurosci. 13, 623977 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, X., Yu, S., Li, F. & Feng, T. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson’s disease. Neurosci. Lett. 599, 115–119 (2015).

Article  CAS  PubMed